blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3076978

EP3076978 - SERINE GLYCEROPHOSPHOLIPID PREPARATION AND METHOD FOR TREATMENT OF SEIZURES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  16.08.2019
Database last updated on 22.08.2024
FormerExamination is in progress
Status updated on  07.12.2018
Most recent event   Tooltip16.08.2019Application deemed to be withdrawnpublished on 18.09.2019  [2019/38]
Applicant(s)For all designated states
Enzymotec Ltd.
Sagee 2000 Industrial Park
P.O. Box 6
23106 Migdal Haemeq / IL
[2016/41]
Inventor(s)01 / ZAAROOR REGEV, Daphna
Gilboa St. 29
3600100 Nofit / IL
02 / HERZOG, Yael
Klil Hachoresh 13
2281500 Gesher Haziv / IL
03 / CHUDNOW, Robert
5224 Windjammer Rd.
Plano TX 75093 / US
04 / RICHTER, Yael
Kibutz Sarid
3658900 36589 Kibutz Sarid / IL
05 / SORIA ARTZI, Gali, Olga
Gilboa St. 29
18960 En-harod Ihud / IL
 [2016/41]
Representative(s)Boult Wade Tennant LLP
Salisbury Square House
8 Salisbury Square
London EC4Y 8AP / GB
[N/P]
Former [2016/41]Boult Wade Tennant
Verulam Gardens
70 Gray's Inn Road
London WC1X 8BT / GB
Application number, filing date14867329.605.12.2014
[2016/41]
WO2014US68833
Priority number, dateUS201361912073P05.12.2013         Original published format: US 201361912073 P
[2016/41]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015085192
Date:11.06.2015
Language:EN
[2015/23]
Type: A1 Application with search report 
No.:EP3076978
Date:12.10.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 11.06.2015 takes the place of the publication of the European patent application.
[2016/41]
Search report(s)International search report - published on:US11.06.2015
(Supplementary) European search report - dispatched on:EP19.07.2017
ClassificationIPC:A61K31/685, A61K47/24, A61P25/08, A61K45/06
[2017/33]
CPC:
A61K31/685 (EP,US); A61K31/202 (US); A61K31/19 (US);
A61K31/216 (US); A61K31/423 (US); A61K31/513 (US);
A61K31/55 (US); A61K31/5513 (US); A61K45/06 (US);
A61K47/24 (US); A61K47/542 (EP,US); A61K47/544 (EP,US);
A61P25/08 (EP); A61P43/00 (EP) (-)
C-Set:
A61K31/685, A61K2300/00 (EP,US)
Former IPC [2016/41]A61K31/66, A61K47/48, A61P25/08
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/41]
TitleGerman:HERSTELLUNG VON SERINGLYCEROPHOSPHOLIPID UND VERFAHREN ZUR BEHANDLUNG VON ANFÄLLEN[2016/41]
English:SERINE GLYCEROPHOSPHOLIPID PREPARATION AND METHOD FOR TREATMENT OF SEIZURES[2016/41]
French:PRÉPARATION DE GLYCÉROPHOSPHOLIPIDES DE SÉRINE ET MÉTHODE DE TRAITEMENT DE CRISES D'ÉPILEPSIE[2016/41]
Entry into regional phase28.06.2016National basic fee paid 
28.06.2016Search fee paid 
28.06.2016Designation fee(s) paid 
28.06.2016Examination fee paid 
Examination procedure28.06.2016Examination requested  [2016/41]
26.01.2018Amendment by applicant (claims and/or description)
10.12.2018Despatch of a communication from the examining division (Time limit: M04)
24.04.2019Application deemed to be withdrawn, date of legal effect  [2019/38]
15.05.2019Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2019/38]
Fees paidRenewal fee
30.12.2016Renewal fee patent year 03
28.12.2017Renewal fee patent year 04
31.12.2018Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]US2009074857  (DROR GAI BEN [IL], et al) [Y] 1-18* claims 1-4, 13-20 *;
 [Y]  - YUEN A W C ET AL, "Omega-3 fatty acid supplementation in patients with chronic epilepsy: A randomized trial", EPILEPSY AND BEHAVIOR, ACADEMIC PRESS, SAN DIEGO, CA, US, vol. 7, no. 2, ISSN 1525-5050, (20050901), pages 253 - 258, (20050814), XP027406557 [Y] 1-18 * abstract * * page 254, column 2, paragraph 4 * * page 257, column 2, paragraph 3 - paragraph 4 *
 [Y]  - L PASQUI ET AL, "Effects of phosphatidylserine in an experimental model of generalized epilepsy", RIVISTA DI NEUROLOGIA, (19840301), vol. 54, no. 2, pages 128 - 138, XP055377557 [Y] 1-18 * abstract *
International search[A]US6005004  (KATZ ROBERT [US], et al);
 [Y]US2009074857  (DROR GAI BEN [IL], et al);
 [Y]US2011301238  (BORGES KARIN [AU])
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.